Wells Fargo & Company Issues Positive Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Key Points

• Wells Fargo raised its Bath & Body Works price target from $24 to $25 and maintained an “overweight” rating, implying 11.92% upside from the prior close.
• Analyst sentiment remains mixed: four analysts rate the stock a Buy, 15 rate it Hold, and one rates it Sell, producing a consensus “Hold” rating and $22.20 average price target.
• Bath & Body Works reported quarterly EPS of $0.62, beating the $0.24 consensus estimate, while revenue reached $1.51 billion but declined 2.3% year over year. Institutional investors and hedge funds own 95.14% of the stock.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $24.00 to $25.00 in a research report issued on Thursday, Benzinga reports. The firm currently has an "overweight" rating on the stock. Wells Fargo & Company's price objective indicates a potential upside of 11.92% from the stock's previous close.

A number of other research firms also recently commented on BBWI. Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a report on Tuesday, October 6th. UBS Group cut their target price on shares of Bath & Body Works from $19.00 to $17.00 and set a "neutral" rating for the company in a research note on Thursday, August 27th. Barclays decreased their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 27th. JPMorgan Chase & Co. upped their price target on Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a report on Tuesday, August 18th. Finally, Robert W. Baird cut their price objective on Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $22.20.

Bath & Body Works Stock Performance

Shares of BBWI opened at $22.34 on Thursday. The stock's fifty day moving average is $18.44 and its 200-day moving average is $19.85. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 5.85, a price-to-earnings-growth ratio of 1.05 and a beta of 1.40. Bath & Body Works has a one year low of $14.27 and a one year high of $25.21.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. Bath & Body Works's revenue was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.30 EPS. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Analysts forecast that Bath & Body Works will post 2.73 EPS for the current fiscal year.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently modified their holdings of the stock. Elevation Wealth Partners LLC increased its stake in shares of Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock worth $41,000 after purchasing an additional 1,742 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock worth $48,000 after buying an additional 673 shares during the last quarter. Root Financial Partners LLC boosted its stake in shares of Bath & Body Works by 4,485.7% during the 1st quarter. Root Financial Partners LLC now owns 3,210 shares of the company's stock worth $60,000 after acquiring an additional 3,140 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Bath & Body Works during the 2nd quarter worth about $66,000. Finally, Blue Trust Inc. boosted its stake in shares of Bath & Body Works by 30.0% during the 1st quarter. Blue Trust Inc. now owns 3,643 shares of the company's stock worth $68,000 after acquiring an additional 840 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its merchandise includes body lotions, shower gels, fragrances, soaps, hand sanitizers, candles, air fresheners and other fragrance-focused items sold under the Bath & Body Works brand.

The company operates through a network of retail stores and digital commerce channels, serving customers primarily in the United States and Canada. Its products are also available internationally through select partners, including franchise, wholesale and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc The company became an independent publicly traded business in 2021 after separating from L Brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.